ATE183095T1 - Verwendung von prostaglandin-e1 zur behandlung männlicher erektiler impotenz - Google Patents

Verwendung von prostaglandin-e1 zur behandlung männlicher erektiler impotenz

Info

Publication number
ATE183095T1
ATE183095T1 AT91108655T AT91108655T ATE183095T1 AT E183095 T1 ATE183095 T1 AT E183095T1 AT 91108655 T AT91108655 T AT 91108655T AT 91108655 T AT91108655 T AT 91108655T AT E183095 T1 ATE183095 T1 AT E183095T1
Authority
AT
Austria
Prior art keywords
prostaglandin
male erectile
treat male
impotency
erectile impotency
Prior art date
Application number
AT91108655T
Other languages
English (en)
Inventor
Alberto Reale
Original Assignee
Alberto Reale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11330110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE183095(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alberto Reale filed Critical Alberto Reale
Application granted granted Critical
Publication of ATE183095T1 publication Critical patent/ATE183095T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91108655T 1990-05-31 1991-05-28 Verwendung von prostaglandin-e1 zur behandlung männlicher erektiler impotenz ATE183095T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT08620490A IT1247678B (it) 1990-05-31 1990-05-31 Metodo per la cura dell'impotenza erettiva maschile

Publications (1)

Publication Number Publication Date
ATE183095T1 true ATE183095T1 (de) 1999-08-15

Family

ID=11330110

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91108655T ATE183095T1 (de) 1990-05-31 1991-05-28 Verwendung von prostaglandin-e1 zur behandlung männlicher erektiler impotenz

Country Status (5)

Country Link
EP (1) EP0459377B1 (de)
AT (1) ATE183095T1 (de)
DE (1) DE69131517T2 (de)
ES (1) ES2137153T3 (de)
IT (1) IT1247678B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
JP3901213B2 (ja) * 1994-08-05 2007-04-04 インファルマ・ソシエテ・アノニム ホスファチジルコリンとプロスタグランジンe1及び/又はトロキサールチンとの複合体を含有する、勃起不能の局所治療のための製剤
DE19728103A1 (de) * 1997-07-02 1999-01-07 Winfried Dr Med Heinicke Pharmazeutisches Präparat zur Behandlung erektiler Dysfunktion sowie Injektionshilfe zur Injektion des Präparats
US6399618B1 (en) 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
DE69927154T2 (de) 1998-06-25 2006-06-29 Lavipharm Laboratories, Inc. Vorrichtung und verfahren zur behandlung von erektionsstörungen
US7087240B1 (en) 1998-06-25 2006-08-08 Lavipharm Laboratories Inc. Device and method for the treatment of erectile dysfunction

Also Published As

Publication number Publication date
ES2137153T3 (es) 1999-12-16
IT9086204A0 (it) 1990-05-31
IT1247678B (it) 1994-12-28
DE69131517D1 (de) 1999-09-16
IT9086204A1 (it) 1991-12-01
EP0459377B1 (de) 1999-08-11
EP0459377A2 (de) 1991-12-04
EP0459377A3 (en) 1992-09-16
DE69131517T2 (de) 2000-01-13

Similar Documents

Publication Publication Date Title
DE69529173D1 (de) Heterozyklische bizykeln zur behandlung von impotenz
DE3752112D1 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
DE69130529D1 (de) Behandlung von erektionversagen
MY106528A (en) Method of treating impotence.
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE120091T1 (de) Vip-konjugate und deren aktive fragmente mit hydrophoben anteilen und topische zuberetungen zur verwendung in der behandlung männlicher impotenz.
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
FR2411821A1 (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et 1-hydroxyoctahydrophenanthrene-9-ones et medicament les contenant
ZA814607B (en) 2-pohenyl-1,2-benzisoselelenazol-3(2h)-one containing pharmaceutical preparations and their use
ATE183095T1 (de) Verwendung von prostaglandin-e1 zur behandlung männlicher erektiler impotenz
HUP9902094A2 (hu) PGE-1-tartalmú liofilizált liposzómák erekciós zavar kezelésében való alkalmazásra
IT1212847B (it) Protesi peniena semirigida per il trattamento dell'impotenza nella erezione maschile.
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
ES8400742A1 (es) Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co.
DK1150698T3 (da) Anvendelser af vaskulær endotelvækstfaktor i behandlingen af erektil dysfunktion
DE69218246D1 (de) Pyridylguanidine verbindungen zur behandlung von erektionsstörungen
MC1930A1 (fr) Produit antiviral
KR880004810A (ko) 소화성 궤양 치료제
ATE83381T1 (de) Verwendung von rekombiniertem menschlichem alpha- interferon zur herstellung eines arzneimittels zur behandlung des aids-virus.
ATE78407T1 (de) Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten.
ATE144141T1 (de) Verwendung von atipamezol zur behandlung der männlichen sexuellen impotenz
KR890007737A (ko) 진토작용을 하는 약제
ES2072910T3 (es) Utilizacion de un compuesto que contiene germanio organico para la fabricacion de un medicamento para el tratamiento del sida.
KR890001555A (ko) 요산 배설용 조성물

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
RZN Patent revoked